Lambestone Holding Limited (CLONE) - Central Bank of Ireland Issues Warning on Unauthorised Firm

What Changed

• - The CBI has formally designated Lambestone Holding Limited (CLONE) as an unauthorised investment firm, investment business firm and crypto‑asset service provider for Ireland, and has published its details on the CBI list of unauthorised firms under
• The warning confirms that Lambestone Holding Limited (CLONE) is not authorised to operate as an investment firm or to provide crypto‑asset services in Ireland, and therefore may not lawfully provide MiFID‑type investment services or crypto‑asset serv
• The CBI explicitly identifies Lambestone Holding Limited (CLONE) as a “clone firm” that has copied the name, address and CRO number of a legitimate company in the Companies Registration Office (CRO) to create an impression of legitimacy.
• The CBI clarifies that there is no connection whatsoever between the legitimate CRO‑registered company and the scam entity, thereby protecting the reputation of the genuine firm and reducing confusion for market participants.
• The warning includes a non‑exhaustive list of websites, email domains and telephone numbers used by the clone (multiple .com domains, support and individual email accounts, and international phone numbers) to assist firms and consumers in screening a
• The publication reiterates that any person can report suspected unauthorised firms directly to the CBI and provides a dedicated contact number and reference to the CBI’s “financial scams” information hub, reinforcing existing expectations on vigilanc

Suggested Considerations

• Update internal sanctions, fraud, and high‑risk entity screening lists immediately to include Lambestone Holding Limited (CLONE), its known websites, email addresses and telephone numbers, and ensure these are used in client onboarding, periodic KYC reviews and transaction monitoring.
• Instruct client‑facing and dealing staff not to refer clients to, or accept instructions from, Lambestone Holding Limited (CLONE) or any individual using the listed domains, emails or phone numbers, and document this in internal guidance.
• Review and enhance client‑due‑diligence procedures to include explicit checks for clone‑firm indicators, including mismatches between a firm’s claimed regulatory status and the CBI online registers, as well as verification against CRO records.
• Implement a formal process to monitor and log Central Bank of Ireland warning notices (and similar notices from ESMA, other EU national competent authorities, FCA, etc.) and to propagate relevant alerts across first‑ and second‑line control functions.
• Conduct targeted staff awareness and training sessions for front‑office, call‑centre, and complaints‑handling teams on clone‑firm typologies, with Lambestone Holding Limited (CLONE) used as a current example of CRO‑identity cloning.
• Review website links, marketing materials and third‑party referral arrangements to ensure the firm does not inadvertently reference or link to any of the Lambestone‑branded domains or intermediaries connected with the clone.

Key Dates

Who is Affected